Home/Filings/4/0001415889-25-010879
4//SEC Filing

Yu Yong 4

Accession 0001415889-25-010879

CIK 0001231457other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 4:56 PM ET

Size

5.1 KB

Accession

0001415889-25-010879

Insider Transaction Report

Form 4
Period: 2025-03-14
Yu Yong
VP, Clinical Trial Operations
Transactions
  • Award

    Common Stock

    2025-03-14+13,35053,219 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025.

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1
  • filerCIK 0001937482

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:56 PM ET
Size
5.1 KB